DOI Services Persistent Identifiers for Scholarly Research
You are viewing the preserved copy. Open the article on the journal's website →

International Journal Of Medical And Pharmaceutical Research • pp. 1-10

NANOTECHNOLOGY BASED DRUG DELIVERY SYSTEMS FOR EFFECTIVE CANCER TREATMENT

  • Sana Afzal BS, Department of Computer Science, The Cosmic Degree College (For Women) ,University of Okara

Abstract

Cancer remains one of the most significant challenges in modern medical science, creating a continuous need for

safer, more effective, and targeted treatment approaches. Conventional cancer treatments, including chemotherapy

and radiotherapy, are widely used but may cause serious side effects because therapeutic drugs can also affect

healthy cells and tissues. Nanotechnology-based drug delivery systems have emerged as an advanced approach to

improving cancer treatment by transporting therapeutic agents through specially designed nanoscale carriers.

These systems include liposomes, polymeric nanoparticles, dendrimers, lipid-based nanoparticles, metallic

nanoparticles, and other advanced nanocarriers. They can improve drug solubility, stability, circulation time, and

targeted delivery while supporting controlled drug release at specific tumor sites. Nanotechnology also provides

opportunities for combining chemotherapy, gene therapy, immunotherapy, and diagnostic procedures within

advanced therapeutic platforms. Recent research highlights the potential of smart nanocarriers that respond to

biological conditions such as temperature, pH, and enzyme activity. However, challenges related to toxicity,

biocompatibility, manufacturing costs, tumor penetration, and clinical approval remain important concerns. This

research examines the applications, advantages, limitations, and future possibilities of nanotechnology-based drug

delivery systems in cancer treatment. The study emphasizes that continued scientific research, clinical evaluation,

and technological development are essential for improving the safety and effectiveness of nanomedicine and

supporting more personalized cancer treatment approaches.

Record

Identifier
https://doi-services.com/1140/228
Published
2026-09-08
Version
1
Original
https://studentsconsultancyhome.com/season-2/journal/index.php/IJMPR/article/view/228